Cargando…
Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study
BACKGROUND: Clinical trials investigating the effects of beta-blockers (BBs) on cancer are underway. Evidence from preclinical research suggests that BBs could serve as anticancer agents and immune boosters. There is conflicting evidence regarding the effect of BB use on clinical outcomes in patient...
Autores principales: | Hsieh, Hui-Hsia, Wu, Tien-Yuan, Chen, Chi-Hua, Kuo, Yu-Hung, Hour, Mann-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288415/ https://www.ncbi.nlm.nih.gov/pubmed/37359444 http://dx.doi.org/10.1177/20420986231181338 |
Ejemplares similares
-
Survival Outcomes of Calcium Channel Blocker Therapy in Patients With Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Inhibitors: A Retrospective Study
por: Hsieh, Hui-Hsia, et al.
Publicado: (2023) -
Clinical impact of tetracyclines and/or proton pump inhibitors on the efficacy of epidermal growth factor receptor inhibitors in non-small cell lung cancer: a retrospective cohort study
por: Hsieh, Hui-Hsia, et al.
Publicado: (2023) -
Cost-effectiveness and clinical outcomes of intermittent/continuous proton pump inhibitors infusion in high bleeding risk of ulcers: A retrospective observational cohort study
por: Hsieh, Hui-Hsia, et al.
Publicado: (2021) -
The Influence of Pre-Existing Beta-Blockers Use on Survival Outcomes in HER2 Positive Advanced Breast Cancer: Pooled Analysis of Clinical Trial Data
por: Modi, Natansh D., et al.
Publicado: (2020) -
The Usage of Concomitant Beta-Blockers with Vasopressors and Inotropes in Cardiogenic Shock
por: Ryu, Rachel, et al.
Publicado: (2022)